Publication | Closed Access

A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617

Hematological MalignancyOncologyMedicineAcute Myeloid LeukemiaHematologyPharmacotherapyPharmacologyOlder PatientsChemotherapyCancer ResearchInduction ChemotherapyMyeloid Neoplasia